Quarterly Journal of Nuclear Medicine and Molecular Imaging

Papers
(The TQCC of Quarterly Journal of Nuclear Medicine and Molecular Imaging is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Osteomyelitis in complicated bones: the role of FDG PET/CT25
Targeted alpha therapy in prostate cancer: review of available agents in clinical practice21
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study15
Nuclear cardiac imaging for the diagnosis and management of heart failure: what can be learned from recent guidelines?13
Respiratory gating in [18F]fluorocholine PET/CT for hyperparathyroidism: a quantitative proof-of-concept study13
Current radioisotopes and radiopharmaceuticals for radiosynoviorthesis: basic and applied characteristics, production and availability11
[68Ga]DOTA-TATE PET for the detection of early transplant rejection in a heterotopic allograft heart transplantation model of the rat: a pilot study10
Pediatric nuclear medicine: continuing the evolution10
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus9
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?9
Combination prostate-specific membrane antigen-targeted radiopharmaceutical therapy in metastatic prostate cancer8
The value of artificial intelligence in PSMA PET: a pathway to improved efficiency and results7
Current and future trends of [18F]FDG PET/CT in pediatric Hodgkin lymphoma7
The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response7
Stereotactic body radiation therapy for the re-irradiation of local relapse from prostate cancer: results in terms of outcomes and toxicity6
Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer6
[18F]FDG and [68Ga]Ga-PSMA dual-tracer total-body PET/CT and PET/MR in patients with prostate cancer6
Radiopharmaceuticals for lung ventilation scintigraphy6
Contemporary SPECT/CT V/Q scanning: protocols, pearls and pitfalls6
Novel radiopharmaceuticals for bladder cancer evaluation6
Second radioiodine treatment hardly benefits TT-DTC patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans6
Radiation protection aspects for alpha therapies6
FDG PET/CT in vascular graft infection: a pictorial review5
Technical concepts on blood pool phase SPECT (acquisition, reconstruction)5
11C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction4
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging4
Imaging tumor microenvironment: clinical experience with 68Ga-FAPI PET/CT across multiple cancer types4
Perceptual omission errors in positron emission tomography and computed tomography reporting4
Nuclear medicine and pediatric nephro-urology: a long-lasting successful partnership4
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review4
Role and interpretation of lung scintigraphy for long-term management of pulmonary embolism4
Innovations in imaging modalities: a comparative review of MRI, long-axial field-of-view PET, and full-ring CZT-SPECT in detecting bone metastases3
Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study3
Emerging topics in neuroimaging3
The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment3
F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data3
Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis3
Novel imaging predictors in pediatric lymphoma: radiomics and artificial intelligence. A systematic review3
Local treatment of synovitis3
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors3
Fever of unknown origin in pediatrics: role of nuclear medicine3
From prostate to bladder cancer: current evidence and expanding horizons in nuclear medicine3
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study3
[18F]FDG PET/CT for the diagnosis of diabetic foot osteomyelitis3
0.08139705657959